Page last updated: 2024-12-07

gamma-glutamyl dopa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID115303
SCHEMBL ID11576781
MeSH IDM0068060

Synonyms (15)

Synonym
l-tyrosine, n-l-gamma-glutamyl-3-hydroxy-
gamma-glutamyldopa
n-l-gamma-glutamyl-3-hydroxy-l-tyrosine
gamma-glutamyl dopa
gludopa
52370-58-8
gamma-glutamyl-3,4-dihydroxyphenylalanine
gamma-glutamyl l-dopa
gamma-glutamyl-dopa
KEKSCSDLHBLBDJ-IUCAKERBSA-N
SCHEMBL11576781
n-(4-amino-4-carboxy-1-hydroxybutylidene)-3-hydroxytyrosine
DTXSID10966749
gamma-glutamyl-l-3,4-dihydroxy phenylalanine
(2s)-2-amino-5-[[(1s)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl]amino]-5-oxopentanoic acid

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" route, elimination followed apparent first order kinetics and was biphasic with a t 1/2 alpha of 7 min and terminal half-life of 67 min."( Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
Cummings, J; Matheson, LM; Maurice, L; Smyth, JF, 1990
)
0.28
" The mean residence time and half-life were 20."( The pharmacokinetics of gamma-glutamyl-L-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure.
Barber, HE; Boateng, YA; Lee, MR; MacDonald, TM; Petrie, JC; Whiting, PH, 1990
)
0.28

Bioavailability

ExcerptReferenceRelevance
" dosing (65 min), and bioavailability was 40%."( Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
Cummings, J; Matheson, LM; Maurice, L; Smyth, JF, 1990
)
0.28
" In a second study the oral bioavailability of gludopa was estimated in normal subjects and found to be low (less than 2%)."( Effect of prolonged intravenous infusion of gludopa in humans and a preliminary study of its oral bioavailability.
Ellis, R; Freestone, S; Lee, MR; MacDonald, TM, 1990
)
0.28
" The oral bioavailability of gludopa is only 1 to 2% and this rules out the dipeptide as an effective dopaminergic prodrug."( Five years' experience with gamma-L-glutamyl-L-dopa: a relatively renally specific dopaminergic prodrug in man.
Lee, MR, 1990
)
0.28

Dosage Studied

ExcerptRelevanceReference
" dosing (65 min), and bioavailability was 40%."( Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
Cummings, J; Matheson, LM; Maurice, L; Smyth, JF, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (35.71)18.7374
1990's23 (54.76)18.2507
2000's2 (4.76)29.6817
2010's2 (4.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.77 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (13.95%)5.53%
Reviews5 (11.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (74.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]